학술논문
A quality of life survey in patients with long-term silicone oil or phthisis bulbi.
Document Type
Academic Journal
Author
Doyle J; Oxford Eye Hospital, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK. Jennifer.doyle307@gmail.com.; Yang Y; Oxford Eye Hospital, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.; Norris JH; Oxford Eye Hospital, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.; Aslam SA; Oxford Eye Hospital, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.; Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, Levels 5-6 West Wing, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.
Source
Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-702X (Electronic) Linking ISSN: 0721832X NLM ISO Abbreviation: Graefes Arch Clin Exp Ophthalmol Subsets: MEDLINE
Subject
Language
English
Abstract
Aim: The aim of this study is to determine whether there is any difference in the quality of life of patients with a blind eye with long-term silicone oil compared to without.
Method: Patients with either long-term silicone oil in situ (N = 17), defined as a period greater than 6 months duration with no plan for future removal, or those with a phthisical, non oil-filled eye were identified (N = 13). Two validated questionnaires (NEI VFQ-25 and the FACE-Q) that cover indicators for visual function, pain and cosmesis were sent to all patients in the two cohorts.
Results: There was no significant difference found in quality of life outcomes between the two groups in terms of visual function, pain or cosmesis.
Conclusion: The results of this study support a holistic approach to the consent process before vitreoretinal surgery. Patients that may need to undergo multiple vitreoretinal procedures, where the endstage result is a long-term silicone oil fill, should be informed that their functional outcome may be similar to having no surgical intervention.
Method: Patients with either long-term silicone oil in situ (N = 17), defined as a period greater than 6 months duration with no plan for future removal, or those with a phthisical, non oil-filled eye were identified (N = 13). Two validated questionnaires (NEI VFQ-25 and the FACE-Q) that cover indicators for visual function, pain and cosmesis were sent to all patients in the two cohorts.
Results: There was no significant difference found in quality of life outcomes between the two groups in terms of visual function, pain or cosmesis.
Conclusion: The results of this study support a holistic approach to the consent process before vitreoretinal surgery. Patients that may need to undergo multiple vitreoretinal procedures, where the endstage result is a long-term silicone oil fill, should be informed that their functional outcome may be similar to having no surgical intervention.